Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Res ; 53(24): 6011-6, 1993 Dec 15.
Article in English | MEDLINE | ID: mdl-8261415

ABSTRACT

Severe combined immunodeficient (scid) C.B-17 mice are deficient in variable (diversity) joining region recombination, the process of assembling the immunoglobulin and T-cell receptor genes from gene segments, thereby creating much of the enormous diversity of antigen-binding capacity, scid mice are also sensitive to ionizing radiation, as a result of their deficiency in double-strand break repair. Here we report the complementation of the radiation-sensitive scid phenotype by transferring human chromosome 8 into scid cells. Somatic cell hybrids were generated by fusing scid cells with human HT-1080 cells, resulting in radioresistant hybrids with several human chromosomes. One of the identified human chromosomes in the radioresistant scid cell line 4.61, which retains only two human chromosomes, is a rearranged 8/21 translocation. Proof that chromosome 8 confers the complementation was achieved by transferring only human chromosome 8 into scid cells by microcell-mediated chromosome transfer (scid/hu8 cell line). The presence of chromosome 8 in our scid/hu8 cell line was monitored by fluorescence in situ hybridization and polymerase chain reaction. We demonstrated the radioresistance of this hybrid not only to high dose rate but also to low dose rate radiation. We also showed that transference of human chromosome 8 to scid cells fully complements the DNA double-strand break repair deficiency and the high sensitivity of scid cells to radiation-induced chromosome aberrations. Mapping the scid gene to human chromosome 8 is an important first step in cloning the scid gene, which will enhance our understanding of double-strand break repair pathways in humans.


Subject(s)
Chromosomes, Human, Pair 8 , Mice, SCID/genetics , Radiation Tolerance , Animals , Base Sequence , Cell Line , Chromosome Aberrations , DNA Repair , Genetic Complementation Test , Humans , Hybrid Cells , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Phenotype
2.
Int J Radiat Oncol Biol Phys ; 22(4): 681-4, 1992.
Article in English | MEDLINE | ID: mdl-1544836

ABSTRACT

One approach to understanding the mechanism of selective hypoxic cell killing by the benzotriazine-di-N-oxide, SR 4233, is to characterize cell lines that exhibit increased resistance to killing by this drug. The Chinese Hamster Ovary cell line BL-10 was originally isolated on the basis of its hypersensitivity to killing by bleomycin. It is 2.7-fold more resistant to hypoxic cell killing by SR 4233 than wild-type CHO on comparison of D0's. However, both BL-10 and CHO possess the same sensitivity to killing by SR 4233 under aerobic conditions. We have excluded the explanation that differential metabolism of SR 4233 is responsible for its increased survival as both BL-10 and CHO produce the two-electron product SR 4317 at the same rate (3 nmoles/hr/10(6) cells). Analysis of free radical production, DNA double-strand break induction, and glutathione (GSH) levels suggested that the resistance of BL-10 to killing by SR 4233 might result from increased intracellular radical scavenger pathways. Using buthionine sulfoximine (BSO) to decrease cellular GSH levels, we found a marked increase in the sensitivity of BL-10 cells to SR 4233 killing under hypoxia, but a much smaller increase in the sensitivity of CHO cells. Taken together, these data imply that the high GSH levels in BL-10 cells is responsible for its resistance to SR 4233 cytotoxicity.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Survival/drug effects , Prodrugs/pharmacology , Triazines/pharmacology , Animals , CHO Cells , Cell Hypoxia/drug effects , Cricetinae , DNA/drug effects , Dose-Response Relationship, Drug , Drug Resistance , Free Radicals , Glutathione/physiology , Tirapazamine
3.
Int J Radiat Oncol Biol Phys ; 22(4): 701-5, 1992.
Article in English | MEDLINE | ID: mdl-1544841

ABSTRACT

SR 4233 (1,2,4-benzotriazine-3-amine 1,4-dioxide) will soon be entering Phase I clinical trials as a new bioreductive cytotoxic agent for the treatment of solid tumors in combination with fractionated radiotherapy. We have selected 3 from over 50 analogues of SR 4233 which showed particular promise as second generation bioreductive antitumor agents. These compounds, when compared to SR 4233, have higher hypoxic toxicity and comparable or higher oxic to hypoxic cytotoxicity ratios in vitro and similar animal toxicity. We have compared the effectiveness of these three compounds with SR 4233 in two tumor systems and have examined some pharmacokinetic properties. The results show that replacement of the amino group at the 3-position of SR 4233 with either a hydrogen or an N,N-dialkylaminoalkylamino group shortens the half-life of these compounds in the blood because of the combined effects of partition coefficients, basicity, and higher reactivity. SR 4754 and SR 4755, the N,N-dialkylaminoalkylamino derivatives, exhibited shorter plasma half-lives than SR 4233 but exhibited lower anti-tumor activity than SR 4233 based on equal mouse toxicity in a fractionated regimen. SR 4482, with the hydrogen substitution and very high electron affinity, possessed a very short blood half life yet retained similar anti-tumor activity as SR 4233.


Subject(s)
Antineoplastic Agents/therapeutic use , Neoplasms, Experimental/drug therapy , Prodrugs/therapeutic use , Triazines/therapeutic use , Animals , Antineoplastic Agents/pharmacokinetics , Cell Hypoxia/drug effects , Cell Hypoxia/radiation effects , Cell Survival/drug effects , Cell Survival/radiation effects , Female , Mice , Mice, Inbred C3H , Neoplasm Transplantation , Prodrugs/pharmacokinetics , Tirapazamine , Triazines/pharmacokinetics
4.
Proc Natl Acad Sci U S A ; 88(4): 1394-7, 1991 Feb 15.
Article in English | MEDLINE | ID: mdl-1996340

ABSTRACT

C.B-17 severe combined immunodeficient (scid) mice carry the scid mutation and are severely deficient in both T cell- and B cell-mediated immunity, apparently as a result of defective V(D)J joining of the immunoglobulin and T-cell receptor gene elements. In the present studies, we have defined the tissue, cellular, and molecular basis of another characteristic of these mice: their hypersensitivity to ionizing radiation. Bone marrow stem cells, intestinal crypt cells, and epithelial skin cells from scid mice are 2- to 3-fold more sensitive when irradiated in situ than are congenic BALB/c or C.B-17 controls. Two independently isolated embryo fibroblastic scid mouse cell lines display similar hypersensitivities to gamma-rays. In addition, these cell lines are sensitive to cell killing by bleomycin, which also produces DNA strand breaks, but not by the DNA crosslinking agent mitomycin C or UV irradiation. Measurement of the rejoining of gamma-ray-induced DNA double-strand breaks by pulsed-field gel electrophoresis indicates that these animals are defective in this repair system. This suggests that the gamma-ray sensitivity of the scid mouse fibroblasts could be the result of reduced repair of DNA double-strand breaks. Therefore, a common factor may participate in both the repair of DNA double-strand breaks as well as V(D)J rejoining during lymphocyte development. This murine autosomal recessive mutation should prove extremely useful in fundamental studies of radiation-induced DNA damage and repair.


Subject(s)
DNA Damage , DNA Repair , DNA/radiation effects , Immunologic Deficiency Syndromes/genetics , Mutation , Animals , Cell Survival/radiation effects , Cells, Cultured , Dose-Response Relationship, Radiation , Fibroblasts/radiation effects , Gamma Rays , Mice , Mice, Inbred BALB C , Mice, Inbred Strains , Mice, Mutant Strains , Organ Specificity , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...